AMICUS THERAPEUTICS, INC. Forms 3, 4 and 5: Other
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 7 rows, 7 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2023-08-23: Reporting owner Harford Simon N.R.; Form 3; Security No securities are beneficially owned; Transaction Holding.
- 2020-12-02: Reporting owner Kelly Michael Aaron; Form 3; Security No securities are beneficially owned; Transaction Holding.
- 2019-05-17: Reporting owner WHITMAN BURKE W; Form 3; Security No Securities Beneficially Owned; Transaction Holding.
- 2015-03-20: Reporting owner Yu Julie; Form 4; Security Stock Opitons (right to buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2023-08-23 holding as of filing | Harford Simon N.R. Officer (Chief Financial Officer) | 3 | No securities are beneficially owned Non-derivative · Direct | Holding | 0 owned after | no price filed | 2023-08-23 | |
| 2020-12-02 holding as of filing | Kelly Michael Aaron Director | 3 | No securities are beneficially owned Non-derivative · Direct | Holding | 0 owned after | no price filed | 2020-12-02 | |
| 2019-05-17 holding as of filing | WHITMAN BURKE W Director | 3 | No Securities Beneficially Owned Non-derivative · Direct | Holding | 0 owned after | no price filed | 2019-05-17 | |
| 2015-03-20 | Yu Julie Officer (VP Clinical Ops & Data Mgmt) | 4 | Stock Opitons (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −715 9,026 owned after | $2.52 exercise price | 2015-03-25 | |
| 2013-01-28 | Lockhart David J Officer (Chief Scientific Officer) | 4 | Common Stock (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +100,000 100,000 owned after | $3.53 exercise price | 2013-01-30 | |
| 2013-01-28 | Winterbottom Joan Officer (SVP, Human Resources) | 4 | Common Stock (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +33,500 33,500 owned after | $3.53 exercise price | 2013-01-30 | |
| 2012-02-23 holding as of filing | Quimi Daphne Officer (Corporate Controller) | 3 | Stock Optons (right to buy) Derivative · Direct | Holding | $2.81 exercise price | 2012-02-23 |